Amalia Monroy-Ostria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amalia Monroy-Ostria has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Adelaido Chiñas-Pérez
H. Ayuntamiento de Calakmul, Halaltun, 24640 Xpujil, CAM, Mexico
1 shared publication- Alicia Ramírez-Ramírez
Instituto Nacional de Perinatología, Departamento de Infectología e Inmunología, Ciudad de México, México, USA
1 shared publication Chakrit Hirunpetchara T
The Queensland Institute of Medical Research, 300 Herston Road, Brisbane 4029, Australia
1 shared publication- Eiji Kobayashi
Division of Basic Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi 180-8602, Tokyo, Japan
1 shared publication - Juan Carlos Cancino Díaz
Laboratorio de Inmunomicrobiología, Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional, Mexico City 11340, Mexico
1 shared publication - Luis Favila-Castillo
Instituto Politécnico Nacional
1 shared publication
Latest Publications
- Open Access
- 18 October 2016
- Published by Wiley in BioMed Research International
- Vol. 2016, 1-8
NRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis
Cutaneous leishmaniasis (CL) is endemic in Campeche state, Mexico. Host and parasite factors are involved in the establishment and development of CL. Host factors include immune response and genetic background. NRAMP1 (Natural Resistance Associated Macrophage Protein 1) is important in innate immunity. Polymorphisms inNRAMP1have been associated with susceptibility or resistance to infectious and autoimmune diseases. To study the association ofNRAMP1mutations with CL in patients from Calakmul, Campeche, samples from 115 CL patients and 69 samples of healthy people from the same area were evaluated. Five regions inNRAMP1were amplified and digested, looking for mutations in the promoter region (−524G/C), exon 3 (274C/T), exon 8 (823 C7T), and exon 15 (G/A) and deletion of 4 bp in the 3′UTR region. We found a statistical association between polymorphisms in 3′UTR region and exon 8 and CL [;; OR = 17.00; IC of 95% (2.24–128.99)]. Some patients who needed more than 40 doses of Glucantimeto heal injuries presented mutations in exons 3, 8, and 15. Multiple or ear lesions were not associated withNRAMP1polymorphism.- 18 October 2016
- Published by Wiley in BioMed Research International
- Vol. 2016, 1-8
Open AccessNRAMP1 Polymorphisms like Susceptibility Marker in Mexican Focus of Cutaneous Leishmaniasis
Cutaneous leishmaniasis (CL) is endemic in Campeche state, Mexico. Host and parasite factors are involved in the establishment and development of CL. Host factors include immune response and genetic background. NRAMP1 (Natural Resistance Associated Macrophage Protein 1) is important in innate immunity. Polymorphisms inNRAMP1have been associated with susceptibility or resistance to infectious and autoimmune diseases. To study the association ofNRAMP1mutations with CL in patients from Calakmul, Campeche, samples from 115 CL patients and 69 samples of healthy people from the same area were evaluated. Five regions inNRAMP1were amplified and digested, looking for mutations in the promoter region (−524G/C), exon 3 (274C/T), exon 8 (823 C7T), and exon 15 (G/A) and deletion of 4 bp in the 3′UTR region. We found a statistical association between polymorphisms in 3′UTR region and exon 8 and CL [;; OR = 17.00; IC of 95% (2.24–128.99)]. Some patients who needed more than 40 doses of Glucantimeto heal injuries presented mutations in exons 3, 8, and 15. Multiple or ear lesions were not associated withNRAMP1polymorphism. - 1 July 1996
- Published by Wiley in Parasite Immunology
- Vol. 18 (7) , 325-331
Protection of rats against malaria by a transplanted immune spleen
A number of reports have suggested that the spleen plays a key role in the regulation of immunity to malaria but the role, if any, of other tissues is less clear. Furthermore, numerous functional changes occur in the spleen following malaria infection and it is not known whether the spleen’s role relates primarily to its content of malaria‐specific lymphocytes or to the altered structure and function that has occurred. To address these issues we have generated splenic chimeras by transplanting spleens between Plasmodium berghei‐immune and naive rats. In the absence of a functional spleen, specific immune responses from both isolated splenic and non‐splenic cells can partially control infection. However, an immune spleen in a naive rat can solidly protect the animal from malaria and a normal spleen in an otherwise immune rat can provide enhanced protection over the non‐splenic state. Thus, in the presence of functional splenic architecture both splenic and non‐splenic malaria‐specific lymphocytes operate more effectively. However, these studies do demonstrate an important role for non‐splenic tissue in immunity at least for P. berghei in the rat. The study could have important implications for induction of protective immune responses by vaccination and suggests that malaria‐specific lymphocyte responses induced in the periphery following vaccination could interact with parasites in both spleen‐dependent and spleen‐independent ways.
- 1 July 1996
- Published by Wiley in Parasite Immunology
- Vol. 18 (7) , 325-331
Protection of rats against malaria by a transplanted immune spleen
A number of reports have suggested that the spleen plays a key role in the regulation of immunity to malaria but the role, if any, of other tissues is less clear. Furthermore, numerous functional changes occur in the spleen following malaria infection and it is not known whether the spleen’s role relates primarily to its content of malaria‐specific lymphocytes or to the altered structure and function that has occurred. To address these issues we have generated splenic chimeras by transplanting spleens between Plasmodium berghei‐immune and naive rats. In the absence of a functional spleen, specific immune responses from both isolated splenic and non‐splenic cells can partially control infection. However, an immune spleen in a naive rat can solidly protect the animal from malaria and a normal spleen in an otherwise immune rat can provide enhanced protection over the non‐splenic state. Thus, in the presence of functional splenic architecture both splenic and non‐splenic malaria‐specific lymphocytes operate more effectively. However, these studies do demonstrate an important role for non‐splenic tissue in immunity at least for P. berghei in the rat. The study could have important implications for induction of protective immune responses by vaccination and suggests that malaria‐specific lymphocyte responses induced in the periphery following vaccination could interact with parasites in both spleen‐dependent and spleen‐independent ways.